Industry | |
---|---|
Founders |
|
Headquarters | Boston, Massachusetts |
Key people | |
Products | |
Number of employees |
|
Website | www |
Dotmatics is an R&D scientific software company used by scientists in the R&D process that help them be more efficient in their efforts to innovate. Founded in 2005, the company's primary office is in Boston with 14 offices around the globe.[1] In March 2021, Insightful Science acquired Dotmatics.[2] In April 2022, the two companies consolidated under the Dotmatics brand with Insightful Science CEO Thomas Swalla leading the new Dotmatics.[3] Dotmatics' software is used by 2 million scientists and researchers and 10,000 customers.[4]
Dotmatics offers a cloud-based data management platform to support the R&D process and a series of software applications used by scientists that include GraphPad Prism, SnapGene, Geneious Prime, Geneious Biologics, Lab Archives, OMIQ, Protein Metrics, nQuery, Cytapex Bioinformatics, De Novo, SoftGenetics,[5] and M-Star.[6][7]
In October 2023, Dotmatics released a multimodal drug discovery platform named Luma. Luma is a low-code SaaS platform that aggregates relevant data across instruments and software into clean data structures for AI and ML-based analysis.[4]
Dotmatics is backed by Insight Partners, a venture capital and private equity firm.[8]
:3
was invoked but never defined (see the help page).:4
was invoked but never defined (see the help page).